Fortis Malar Hospitals Ltd.
Snapshot View

57.30 -1.05 ▼-1.8%

25 November 2022, 04:01:00 PM
Volume: 1,075

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.fortismalar.com
Market Cap 108.33 Cr.
Enterprise Value(EV) 93.78 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -5.60 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-09
Industry PE 49.95 Trailing Twelve Months Ending 2022-09
Book Value / Share 38.98 Trailing Twelve Months Ending 2022-09
Price to Book Value 1.47 Calculated using Price: 57.30
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.87 Cr. 18,741,759 Shares
FaceValue 10
Company Profile
Malar Hospitals (an Associate of Fortis Healthcare), like every other Fortis hospital, is a manifestation of the founder's vision of creating a world-class integrated healthcare delivery system in India, entailing the finest medical skills combined with compassionate patient care.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-1.80%
1 Week
-2.05%
1 Month
+5.72%
3 Month
-1.38%
6 Month
+5.23%
1 Year
-10.47%
2 Year
+14.60%
5 Year
-4.42%
10 Year
+52.80%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 10.84 8.93 6.80 3.16 3.28 1.97 -8.82 -8.50 -9.80
Return on Capital Employed (%) 17.10 14.17 10.96 5.00 5.90 3.17 -4.09 -4.44 -2.02
Return on Assets (%) 9.13 6.85 4.97 2.40 2.40 1.39 -5.27 -4.51 -5.29

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 85 91 98 100 103 105 96 89 80 73
Non Curr. Liab. 1 0 0 0 0 0 56 47 41 41
Curr. Liab. 16 37 32 30 45 44 36 25 31 35
Minority Int.
Equity & Liab. 101 128 130 130 148 149 188 161 152 149
Non Curr. Assets 20 20 28 33 34 37 126 101 103 98
Curr. Assets 82 108 102 97 113 112 62 60 49 51
Misc. Exp. not W/O
Total Assets 101 128 130 130 148 149 188 161 152 149

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 108 118 130 141 149 145 112 69 86 86
Other Income 7 8 9 8 8 10 11 8 7 7
Total Income 115 126 138 149 158 155 123 78 94 93
Total Expenditure -99 -110 -124 -140 -147 -147 -115 -76 -83 -81
PBIDT 16 15 14 9 10 8 8 2 11 12
Interest 0 -1 0 0 0 -1 -8 -7 -7 -6
Depreciation -2 -3 -3 -4 -4 -4 -13 -13 -13 -12
Taxation -5 -4 -4 -1 -2 -1 3 3 0 -4
Exceptional Items -1 7
PAT 9 8 6 3 3 2 -9 -8 -8 -11
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 9 8 6 3 3 2 -9 -8 -8 -10
Adjusted EPS 5 4 3 2 2 1 -5 -4 -4 -6

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -64 5 4 10 -9 9 -16 0 -1 7
Cash Fr. Inv. 73 -1 5 -22 13 -2 6 50 -28 8
Cash Fr. Finan. -7 -1 -1 -1 0 0 -12 -7 -10
Net Change 2 3 10 -13 4 7 -9 38 -36 5
Cash & Cash Eqvt 3 6 16 3 7 15 5 43 7 12

Shareholding Pattern View Details >>

9 Qtrs 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%)
Promoter 62.71 62.71 62.71 62.71 62.71 62.71 62.71 62.71 62.71
Public 37.29 37.29 37.29 37.29 37.29 37.29 37.29 37.29 37.29
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 18 Nov 2022
Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 ("SEBI LODR").
In compliance of Regulation 23(9) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 please find attached disclosure of Related Party Transactions for the half year ended September 30 2022.This is for your information and records please.
Fri, 18 Nov 2022
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 it is hereby informed that the Company is in the receipt of request for issuance of duplicate share certificate due to loss of certificates. You are requested to take the same on your record.
Thu, 17 Nov 2022
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
This is in continuation to our letter dated September 22 2022 September 23 2022 and November 11 2022 please find attached herewith a copy of Stock Exchange intimation submitted by Fortis Healthcare Limited dated November 17 2022 with respect to pending Open Offer of the Company. We will keep the stock exchanges updated / informed regarding material development in this matter.This is for your information and records please.

Technical Scans View Details >>

Fri, 25 Nov 2022
High Delivery Percentage High Delivery Percentage
Opening at High Opening at High
High Increase 1 Month High Increase 1 Month
Closing Near 50 SMA Closing Near 50 SMA
Closing Near 100 SMA Closing Near 100 SMA

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 247,923.28 1,033.85 -0.1%
Cipla Ltd. 89,193.72 1,105.35 +0.9%
Divi's Laboratories Ltd. 88,708.98 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. 73,559.75 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. 68,713.97 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. 55,107.38 1,628.25 +0.8%
Abbott India Ltd. 43,050.55 20,267.50 +0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.40 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-09 34.75 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-09 29.59 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 23.60 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 82.06 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 69.14 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-09 48.82 20,267.50 +0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.67 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-09 4.07 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-09 7.30 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.53 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 11.51 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 9.05 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-09 15.86 20,267.50 +0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 0.04 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 0.00 20,267.50 +0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 13.10 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 29.95 20,267.50 +0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 13.10 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 29.95 20,267.50 +0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,267.50 +0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 798.70 20,267.50 +0.4%

FAQ's On Fortis Malar Hospitals Ltd.

What is Fortis MalarHospital share price?

Can I buy Fortis MalarHospital shares now?

What is the Market Cap of Fortis MalarHospital?

What are the key metrics to analyse Fortis MalarHospital?

What is the 52 Week High and Low of Fortis MalarHospital?

What is the trend of Fortis MalarHospital share price?